Mode
Text Size
Log in / Sign up
N/A N=4,182 Randomized Double-blind Health Services Research

Text Reminders to Immunize in a Managed Care Organization

Human Papilloma Virus

Enrolled (actual)
4,182
Serious AEs
0.0%
Results posted
Jun 2017
Primary outcome: Primary: Percentage of Participants Receiving HPV Vaccination (Dose 1) — 16; 13 percentage of eligible participants — p=<0.04

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Text-based reminder for recommended HPV vaccine or WCC (Other); Non-specific text-based reminder (general health tip) (Other)
Age
Pediatric, Adult · 11+ yrs
Sex
All
Sponsor
University of Rochester
Primary completion
Dec 2014

Outcome Measures

OutcomeResultp-value
PRIMARY
Percentage of Participants Receiving HPV Vaccination (Dose 1)
16; 13 <0.04 sig
SECONDARY
Percentage of Participants Receiving HPV Vaccination (Dose 2)
6; 7
SECONDARY
Percentage of Participants Receiving HPV Vaccination (Dose 3)
2; 2

Summary

The purpose of the study is to evaluate the effectiveness of a managed care-based HPV vaccination reminder/recall system using a randomized controlled trial (RCT) across diverse practices and patient populations. The trial will measure the effectiveness of text messaging reminder/recall on (a) improving initiation and (b) completion rate of the HPV vaccine series; (c) decreasing the time between vaccine doses; and (d) improving rates of preventive visits for adolescents The hypotheses are that text-messaged reminders to parents of adolescents will result in improved rates of HPV vaccine series initiation, HPV vaccine series completion, will decrease the intervals between vaccine doses and will improve rates of preventive care among adolescents. Parents receiving specific text-messaged reminders about services (i.e. HPV vaccination, well child care visits) for which their adolescent is due will be compared to a control group of parents receiving general health tips through text messages.

Eligibility Criteria

Inclusion Criteria

  • 11- 6 months
  • Opted in to receive texted reminders from MCO

Exclusion Criteria

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01806714). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search